KeyCorp Cuts HealthEquity (NASDAQ:HQY) Price Target to $100.00

HealthEquity (NASDAQ:HQY) had its price objective lowered by KeyCorp from $110.00 to $100.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other equities research analysts have also commented on HQY. The Goldman Sachs Group cut their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Thursday, March 27th. Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Finally, Barrington Research restated an “outperform” rating and issued a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, HealthEquity has an average rating of “Buy” and a consensus price target of $111.75.

HealthEquity Stock Performance

Shares of HQY stock opened at $82.49 on Wednesday. The company has a market capitalization of $7.14 billion, a P/E ratio of 75.68, a P/E/G ratio of 1.60 and a beta of 0.49. HealthEquity has a 12-month low of $65.01 and a 12-month high of $115.59. The business’s 50 day moving average is $95.89 and its two-hundred day moving average is $96.26. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,381 shares of company stock worth $1,781,432. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Several institutional investors have recently modified their holdings of the company. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity during the 4th quarter worth about $26,000. Versant Capital Management Inc purchased a new stake in HealthEquity during the first quarter worth approximately $28,000. Transce3nd LLC acquired a new position in HealthEquity in the fourth quarter valued at approximately $29,000. Smartleaf Asset Management LLC boosted its holdings in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC acquired a new stake in HealthEquity during the fourth quarter worth approximately $39,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.